Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)
Clinical SWITCH trial examines surgery versus watch-and-wait in complete responders with hepatocellular carcinoma; the study is currently no…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Comparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma [NA]
Clinical trial comparing combination therapy of transarterial chemoembolization plus lenvatinib versus lenvatinib alone in unresectable hepa…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study [Phase 2]
A Phase 2 trial (The Knight SHIFT Study) is comparing morning versus afternoon administration of immunotherapy for advanced or metastatic so…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis [Phase 4]
A Phase 4 trial comparing gadolinium contrast-enhanced abbreviated MRI versus standard ultrasound for hepatocellular carcinoma surveillance …
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
A French research trial aims to assemble a biological collection to develop preclinical translational models for tumors and chronic liver di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients
A completed clinical trial evaluates whether microRNA biomarkers can diagnose hepatocellular carcinoma in patients with hepatitis C.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization [NA]
A completed clinical trial evaluating short-term embolization using gelatin particles to modulate flow during Y-90 radioembolization for liv…
-
EMA approval · 2026-02-11EMA Authorised: Imjudo (tremelimumab) — AstraZeneca AB
EMA has authorised Imjudo (tremelimumab) from AstraZeneca AB for hepatocellular carcinoma and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC [Phase 1]
Phase 1 trial evaluating NP137 in combination with atezolizumab and bevacizumab for first-line unresectable hepatocellular carcinoma has bee…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma [Phase 3]
Phase 3 randomized trial comparing sorafenib plus pravastatin versus sorafenib alone for palliative treatment of Child-Pugh A hepatocellular…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study [Phase 1]
Phase I trial evaluating intrahepatic arterial injection of a Lipiodol and idarubicin emulsion (Zavedos) for unresectable non-metastatic hep…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: REGULUS: MRI-guided Adaptive SABR for Liver Cancers [Phase 2]
Stanford's REGULUS trial investigates MRI-guided adaptive SABR for liver cancers, including hepatocellular carcinoma and intrahepatic cholan…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma [Phase 1]
This Phase 1 trial investigates Cadonilimab in combination with Regorafenib for advanced hepatocellular carcinoma that has failed at least o…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Phase II Trial of Immunonutrition in Hepatectomy [NA]
This update describes a Phase II trial evaluating immunonutrition in patients undergoing hepatectomy for hepatocellular carcinoma, currently…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial comparing SH006 Injection in combination therapy to Regorafenib for advanced hepatocellular carcinoma, with…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA [NA]
A clinical trial is investigating whether monitoring circulating tumor DNA can predict recurrence of hepatocellular carcinoma after curative…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Registry on Percutaneous Electrochemotherapy
A clinical trial registry update for a percutaneous electrochemotherapy study in primary and secondary liver cancers, sponsored by the Cardi…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC) [NA]
ClinicalTrials.gov entry PSYLIVER-PILOTE describes research on autonomic nervous system involvement in hepatocellular carcinoma, with the st…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma. [Phase 1]
Phase 1 study of MDN-001 Injection for unresectable primary hepatocellular carcinoma is currently recruiting. The sponsor is Suzhou Mednovo …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of SH009 Injection in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial update for SH009 Injection in patients with advanced solid tumors, currently recruiting across multiple indications…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating a Gallium-68 PSMA radiotracer for advanced hepatocellular carcinoma has completed; the document does not p…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma
An ongoing clinical trial in Belgrade is investigating blood-based biomarkers in hepatocellular carcinoma patients treated with transarteria…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers [Phase 1]
Phase 1 exploratory study evaluating FAPi PET/CT imaging with histopathology validation in patients with various cancers. The trial collects…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy
A non-interventional study is investigating the benefits of applying Transjugular Intrahepatic Portosystemic Shunt (TIPS) in hepatocellular …
-
CLINICAL_TRIALS other · 2026-02-05Clinical Trial Update: The PLATON Network
The PLATON Network trial (NCT05489250), sponsored by IKF GmbH at Krankenhaus Nordwest, has been terminated; the study involved hepatocellula…